182 related articles for article (PubMed ID: 20699382)
21. Deficits in the management of patients with adrenocortical carcinoma in Germany.
Johanssen S; Hahner S; Saeger W; Quinkler M; Beuschlein F; Dralle H; Haaf M; Kroiss M; Jurowich C; Langer P; Oelkers W; Spahn M; Willenberg HS; Mäder U; Allolio B; Fassnacht M
Dtsch Arztebl Int; 2010 Dec; 107(50):885-91. PubMed ID: 21246024
[TBL] [Abstract][Full Text] [Related]
22. Less common genotype variants of TP53 polymorphisms are associated with poor outcome in adult patients with adrenocortical carcinoma.
Heinze B; Herrmann LJ; Fassnacht M; Ronchi CL; Willenberg HS; Quinkler M; Reisch N; Zink M; Allolio B; Hahner S
Eur J Endocrinol; 2014 May; 170(5):707-17. PubMed ID: 24566897
[TBL] [Abstract][Full Text] [Related]
23. A clinicopathologic profile of adrenocortical tumors.
Upadhye PS; Desai MP; Colaco MP; Desai PB; Deshpande RK; Mokal RA
Indian Pediatr; 1997 Jun; 34(6):481-90. PubMed ID: 9357203
[TBL] [Abstract][Full Text] [Related]
24. Surgical management and clinical prognosis of adrenocortical carcinoma.
Dong D; Li H; Yan W; Ji Z; Mao Q
Urol Int; 2012; 88(4):400-4. PubMed ID: 22487802
[TBL] [Abstract][Full Text] [Related]
25. Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress?
Kebebew E; Reiff E; Duh QY; Clark OH; McMillan A
World J Surg; 2006 May; 30(5):872-8. PubMed ID: 16680602
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant radiation therapy improves local control after surgical resection in patients with localized adrenocortical carcinoma.
Sabolch A; Else T; Griffith KA; Ben-Josef E; Williams A; Miller BS; Worden F; Hammer GD; Jolly S
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):252-9. PubMed ID: 25754631
[TBL] [Abstract][Full Text] [Related]
27. [RESULTS OF DIAGNOSTICS AND TREATMENT OF ADRENOCORTICAL CANCER].
Romashchenko PN; Maĭstrenko NA; Orlova RV; Babich AI
Vestn Khir Im I I Grek; 2015; 174(3):29-39. PubMed ID: 26390585
[TBL] [Abstract][Full Text] [Related]
28. Adrenocortical pheochromocytoma diagnosed during pregnancy: a case report.
Qiang X; Li Y; Bai Q; Huang J; Ma X; Wang W
BMC Pregnancy Childbirth; 2023 Jul; 23(1):527. PubMed ID: 37464302
[TBL] [Abstract][Full Text] [Related]
29. Serum inhibin pro-αC is a tumor marker for adrenocortical carcinomas.
Hofland J; Feelders RA; van der Wal R; Kerstens MN; Haak HR; de Herder WW; de Jong FH
Eur J Endocrinol; 2012 Feb; 166(2):281-9. PubMed ID: 22127493
[TBL] [Abstract][Full Text] [Related]
30. [Diagnosis and surgical treatment of adrenocortical carcinoma. A review of the literature and report of two cases].
Shon Ch; Mladenovski V; Petkov R; K'tev N; Mikhailov N; Gavrailov M; Trifonov D
Khirurgiia (Sofiia); 2000; 56(2):45-9. PubMed ID: 11484289
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer during pregnancy: maternal and fetal outcomes.
Cardonick E; Dougherty R; Grana G; Gilmandyar D; Ghaffar S; Usmani A
Cancer J; 2010; 16(1):76-82. PubMed ID: 20164696
[TBL] [Abstract][Full Text] [Related]
32. Management of adrenal tumors in pregnancy.
Eschler DC; Kogekar N; Pessah-Pollack R
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):381-97. PubMed ID: 26038207
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in adrenocortical carcinoma in adults.
Bourdeau I; MacKenzie-Feder J; Lacroix A
Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):192-7. PubMed ID: 23549307
[TBL] [Abstract][Full Text] [Related]
34. Conditional survival among patients with adrenal cortical carcinoma determined using a national population-based surveillance, epidemiology, and end results registry.
Xiao WJ; Zhu Y; Dai B; Zhang HL; Shi GH; Shen YJ; Zhu YP; Ye DW
Oncotarget; 2015 Dec; 6(42):44955-62. PubMed ID: 26510907
[TBL] [Abstract][Full Text] [Related]
35. The impact of tumor stage on prognosis in children with adrenocortical carcinoma.
Tucci S; Martins AC; Suaid HJ; Cologna AJ; Reis RB
J Urol; 2005 Dec; 174(6):2338-42, discussion 2342. PubMed ID: 16280838
[TBL] [Abstract][Full Text] [Related]
36. Adrenocortical tumors in childhood.
Narasimhan KL; Samujh R; Bhansali A; Marwaha RK; Chowdhary SK; Radotra BD; Rao KL
Pediatr Surg Int; 2003 Aug; 19(6):432-5. PubMed ID: 12883850
[TBL] [Abstract][Full Text] [Related]
37. The neutrophil-to-lymphocyte ratio (NLR) predicts adrenocortical carcinoma and is correlated with the prognosis.
Mochizuki T; Kawahara T; Takamoto D; Makiyama K; Hattori Y; Teranishi JI; Miyoshi Y; Yumura Y; Yao M; Uemura H
BMC Urol; 2017 Jun; 17(1):49. PubMed ID: 28662713
[TBL] [Abstract][Full Text] [Related]
38. Surgical management of advanced adrenocortical carcinoma: a 21-year population-based analysis.
Tran TB; Liou D; Menon VG; Nissen NN
Am Surg; 2013 Oct; 79(10):1115-8. PubMed ID: 24160811
[TBL] [Abstract][Full Text] [Related]
39. Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors.
Bilimoria KY; Shen WT; Elaraj D; Bentrem DJ; Winchester DJ; Kebebew E; Sturgeon C
Cancer; 2008 Dec; 113(11):3130-6. PubMed ID: 18973179
[TBL] [Abstract][Full Text] [Related]
40. Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection.
Terzolo M; Baudin AE; Ardito A; Kroiss M; Leboulleux S; Daffara F; Perotti P; Feelders RA; deVries JH; Zaggia B; De Francia S; Volante M; Haak HR; Allolio B; Al Ghuzlan A; Fassnacht M; Berruti A
Eur J Endocrinol; 2013 Sep; 169(3):263-70. PubMed ID: 23704714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
